Clinical impact of post procedural mitral regurgitation after transcatheter aortic valve replacement
Eyal Ben–Assa(Massachusetts General Hospital), Yan Topilsky(Tel Aviv University), Michal Laufer‐Perl(Tel Aviv University), Yaron Arbel(Tel Aviv Sourasky Medical Center), Sammy Elmariah(Brigham and Women's Hospital), Ignacio Inglessis(Brigham and Women's Hospital), Judith Kramarz, Shmuel Banai(Tel Aviv Sourasky Medical Center), Ariel Finkelstein, Gad Keren(Assuta Medical Center), Simon Biner
Cited by 26
Related Papers
The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations
|Journal of the American College of Cardiology|2000|731
The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study
|Journal of the American College of Cardiology|2001|646
Neutrophil/lymphocyte ratio is related to the severity of coronary artery disease and clinical outcome in patients undergoing angiography
|Atherosclerosis|2012|390
Role of Naturally Occurring CD4 <sup>+</sup> CD25 <sup>+</sup> Regulatory T Cells in Experimental Atherosclerosis
|Arteriosclerosis Thrombosis and Vascular Biology|2007|347